共 73 条
[1]
Dincer U(2008)Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria Clin Rheumatol 27 457-462
[2]
Cakar E(2002)Ankylosing spondylitis: introductory comments on its diagnosis and treatment Ann Rheum Dis 61 3-7
[3]
Kiralp MZ(2006)Definition of disease duration in ankylosing spondylitis: reassessing the concept Ann Rheum Dis 65 1518-1520
[4]
Dursun H(2002)Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy Arthritis Rheum 46 755-765
[5]
Khan MA(2003)Grassnickel Letal. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis Arthritis Rheum 48 1667-1675
[6]
Davis JC(2009)Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes–an Indian perspective Clin Rheumatol 28 327-331
[7]
Dougados M(2009)Two distinct patterns of ankylosing spondylitis in Moroccan patients Rheumatol Int 29 1423-1429
[8]
Braun J(1987)New criteria for the diagnosis of ankylosing spondylitis Scand J Rheumatol Suppl 65 12-24
[9]
Sieper J(2004)Spinal mobility in ankylosing spondylitis: reliability, validity and responsiveness Rheumatol 43 750-757
[10]
van der Heijde D(2006)The relationship between severity and extent of spinal involvement and spinal mobility and physical functioning in patients with ankylosing spondylitis Clin Rheumatol 25 835-839